Skip navigation
Veuillez utiliser cette adresse pour citer ce document : http://repositorio.unb.br/handle/10482/44375
Fichier(s) constituant ce document :
Fichier Description TailleFormat 
ARTIGO_LycorineAlkaloidCrinum.pdf1,16 MBAdobe PDFVoir/Ouvrir
Affichage complet
Élément Dublin CoreValeurLangue
dc.contributor.authorSilva, Lorene Coelho-
dc.contributor.authorCorreia, Amabel Fernandes-
dc.contributor.authorGomes, João Victor Dutra-
dc.contributor.authorRomão, Wanderson-
dc.contributor.authorMotta, Larissa Campos-
dc.contributor.authorFagg, Christopher William-
dc.contributor.authorBatista, Pérola de Oliveira Magalhães Dias-
dc.contributor.authorSilveira, Dâmaris-
dc.contributor.authorFonseca-Bazzo, Yris Maria-
dc.date.accessioned2022-08-02T21:28:29Z-
dc.date.available2022-08-02T21:28:29Z-
dc.date.issued2022-05-06-
dc.identifier.citationSILVA, Lorene Coelho et al. Lycorine alkaloid and Crinum americanum L. (Amaryllidaceae) extracts display antifungal activity on clinically relevant candida species. Molecules, v. 27, n. 9, 2976, p. 1-12, 2022. DOI 10.3390/molecules27092976. Disponível em: https://www.mdpi.com/1420-3049/27/9/2976. Acesso em: 02 ago. 2022.pt_BR
dc.identifier.urihttps://repositorio.unb.br/handle/10482/44375-
dc.language.isoInglêspt_BR
dc.publisherMDPIpt_BR
dc.rightsAcesso Abertopt_BR
dc.titleLycorine alkaloid and Crinum americanum L. (Amaryllidaceae) extracts display antifungal activity on clinically relevant candida speciespt_BR
dc.typeArtigopt_BR
dc.subject.keywordAntifúngicospt_BR
dc.subject.keywordLicorinapt_BR
dc.subject.keywordCrino americanopt_BR
dc.subject.keywordCandidapt_BR
dc.rights.licenseMolecules - No special permission is required to reuse all or part of article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. Reuse of an article does not imply endorsement by the authors or MDPI. Fonte: https://www.mdpi.com/openaccess. Acesso em: 02 ago. 2022.pt_BR
dc.identifier.doihttps://doi.org/10.3390/molecules27092976pt_BR
dc.description.abstract1Candida species are the main fungal agents causing infectious conditions in hospital patients. The development of new drugs with antifungal potential, increased efficacy, and reduced toxicity is essential to face the challenge of fungal resistance to standard treatments. The aim of this study is to evaluate the in vitro antifungal effects of two crude extracts of Crinum americanum L., a rich alkaloid fraction and lycorine alkaloid, on the Candida species. As such, we used a disk diffusion susceptibility test, determined the minimum inhibitory concentration (MIC), and characterized the components of the extracts using Electrospray Ionization Fourier Transform Ion Cyclotron Resonance Mass Spectrometry (ESI FT-ICR MS). The extracts were found to have antifungal activity against various Candida species. The chemical characterization of the extracts indicated the presence of alkaloids such as lycorine and crinine. The Amaryllidaceae family has a promising antifungal potential. Furthermore, it was found that the alkaloid lycorine directly contributes to the effects that were observed for the extracts and fraction of C. americanum.pt_BR
dc.contributor.emailmailto:lorenecoelho@hotmail.compt_BR
dc.contributor.emailmailto:amabelfernandes@yahoo.com.brpt_BR
dc.contributor.emailmailto:dutra.joaovictor@gmail.compt_BR
dc.contributor.emailmailto:wandersonromao@gmail.compt_BR
dc.contributor.emailmailto:larissacmotta@gmail.compt_BR
dc.contributor.emailmailto:acaciafagg@gmail.compt_BR
dc.contributor.emailmailto:perolamagalhaes@unb.brpt_BR
dc.contributor.emailmailto:damaris@unb.brpt_BR
dc.contributor.emailmailto:yrisfonseca@unb.brpt_BR
Collection(s) :Artigos publicados em periódicos e afins

Affichage abbrégé " class="statisticsLink btn btn-primary" href="/handle/10482/44375/statistics">



Tous les documents dans DSpace sont protégés par copyright, avec tous droits réservés.